ArticleKidney cancer (Clifton, Va.)2022
Extended disease control with unconventional cabozantinib dose increase in metastatic renal cell carcinoma.
Akanksha Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it